illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Biomarin Pharmaceutical
Company logo

Biomarin Pharmaceutical | Sustainability Performance

https://www.biomarin.com/

Develops genetic medicines for rare diseases.

1997

United States

1,001 - 5,000 employees

Biotechnology

$1B - 10B in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#784
Overallⓘ
#198
in United Statesⓘ
#12
in Biotechnologyⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

155 out of 244

Overview
Environmental
Carbon emissionsNature and biodiversity
Social
Diversity and InclusionPay GapsExternalities
Governance
SDG Impact

View similiar companies

Company logo
Arcturus Therapeutics

United States, Health Care, Biotechnology

Company logo
Insmed

United States, Health Care, Biotechnology

Company logo
Exact Sciences

United States, Health Care, Biotechnology

CO2 scope 1 + 2 ⓘDirect emissions from owned or controlled sources, combined with indirect emissions from purchased electricity calculated using grid-average emission factors based on where the energy is consumed.
23.0KCO2e tonnes, 2022
Leading
Female employees ⓘProportion of women in the company's total workforce, expressed as a percentage.
51%2024
Aligned
Externalities ⓘThe monetized estimate of environmental and social impacts caused by an organization that are not reflected in its financial accounts.
3.2M$, 2024
Laggard

Intensity

Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Industry Benchmark

7.1

B/M 10.8


Powered by illuminem and GIST Impact

Reporting

Not reporting on Sustainability

image report
Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

    Available in
    Scale package

    Access
  • Email
  • Email